National Institute of Allergy and Infectious Diseases- Research Projects

NIAID RPG
CFDA 93.8RP Active Grant Cooperative Agreement

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$3.72B FY2026
$3.47B
FY24
$3.79B
FY25
$3.72B
FY26*
* estimated

Program Objective

Provide funding to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.

Eligibility

Eligible Applicants

  • For-Profit Organization
  • Not-for-Profit Organization
  • U.S. State Government
  • Federally Recognized Tribal Government
  • Tribal Government (other)
  • Tribally Designated Housing Authority
  • Municipality/Township Government
  • County Government
  • School District Government
  • Foreign Nonprofit Organization
  • Foreign For-Profit Organization

How to Apply

Award Procedure

Applicants submit the grant application in grants.gov following guidance provided in the Notice of Funding Opportunity (NOFO). Center for Scientific Review (CSR) then assigns the application. A peer review process by Scientific Review Group (SRG) determines an overall impact score or percentile. A second level peer review is done by NIAID’s advisory council which determines if there is concurrence with the initial peer review, program relevance, and fiscal considerations. NIAID selects proposals based on several factors including scientific and technical merit, programmatic priorities/set-asides, and budget availability that fiscal year. The Council makes recommendations to NIAID leadership. After advisory council review NIAID program staff evaluates applications. NIAID officials under delegated HHS authority consider all factors and make funding decisions. The NIAID Grants Management Officer (GMO) issues a Notice of Award (NOA) and only the GMO has authority to obligate federal funds. The NOA is the legally binding document which obligates federal funds. The NOA specifies the approved budget period which is the specific time interval within the project period for which funds are provided.

Decision Timeline

  • Approval: > 180 Days
  • Renewal interval: > 180 Days
  • Appeal: > 180 Days
Program details & compliance

Description

Provide funding to universities and research organizations to study infectious, immunologic, and allergic diseases. These grants and cooperative agreements serve researchers and institutions working to improve public health and protect communities from disease threats. Focus on supporting innovative research that addresses urgent and emerging health challenges, helping to advance scientific knowledge and improve health outcomes for people everywhere.

Mission Categories

Primary: Biology

Other categories:
Research and Development

Required Documentation

Organization must be registered to submit federal grant applications through grants.gov. Information from grants.gov uses your institutions sam.gov registration with a unique entity identifier so that must be active and accurate. The PD/PI needs to have an eRA Commons ID associated with your institution before you can submit the application. Specific documentation requirements for specific applications will be stated in the Notice of Funding Opportunity.

Reporting & Compliance

Audit Required
Yes — Ad-hoc
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

Kevin Richardson — Financial Analyst
3017617870
5601 Fishers Lane Suite 5E48, Rockville, MD 20852
Data from SAM.gov Federal Assistance Listings. Source published: 2026-02-11. Spec v2.0. Last synced: 2026-05-28 07:28:03.